InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Rouan Sarah Kathryn, 董事. Director active across 2 companies, notably Navidea Biopharmaceuticals, INC.. Aggregated, 7 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €55k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rouan Sarah Kathryn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
3,150 股0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003108:0
1,240 股@ US$24.14745.2% 占其流量Common Stock, par value $0.00001 per shareSEC:0000950170-25-052255:0
标准退出：2025年6月29日 (T+90)
1,240 股@ US$24.14745.2% 占其流量Common Stock, par value $0.00001 per shareSEC:0000950170-25-049717:0
标准退出：2025年6月29日 (T+90)
11,000 股@ US$4.889.4% 占其流量Common Stock, par value $0.00001 per shareSEC:0000950170-24-117514:0
25,000 股@ US$8.3236.6% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-24-003008:0
30,000 股@ US$8.3243.5% 占其流量Common Stock, par value $0.00001 per shareSEC:0001209191-24-001973:0
4,892 股0Common StockSEC:0001437749-21-016598:0
7 条申报中的 7 条
About Rouan Sarah Kathryn
Sarah Kathryn Rouan is a Board Member at Navidea Biopharmaceuticals, Inc. She contributes to the governance of the company by bringing her expertise to the board. Her role involves overseeing operations and ensuring compliance with regulations. With her experience, she plays a vital role in strategic decision-making.
